Why Linde, Praxair Deal Has Sprung a Leak

The transcript discusses the challenges faced by Linden and its partners in a merger deal due to US regulatory demands. The US regulators are scrutinizing a facility in Texas, which could breach a self-imposed threshold, making the deal less viable. Despite European approval, the US side remains a hurdle. The potential risk of strengthening competitors is also a concern. Analysts believe the merger will proceed to avoid unraveling complex negotiations.

What concerns do the U.S. regulators have regarding the merger?

What is meant by the 'red line' in the context of the merger discussions?

What are the potential consequences of walking away from the merger?

How might the merger impact competition in the industrial gases market?

What factors could lead to the merger being approved despite regulatory concerns?